MBX Biosciences, Inc. Common Stock
MBX• NASDAQ
$40.97
+6.26+18.02%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: March 2026 · 2026-03-31
Revenue
—
Net income
-$23.52M
Free cash flow
-$20.64M
Diluted EPS
—
Gross margin
—
Profit margin
—
Assets
$452.70M
Cash
$45.21M
Valuation
Market Cap$1.95B
Enterprise Value$1.03B
PE (TTM)—
PE (Fwd)0.00
Price to Sales0.00
EV / EBITDA0.00
Price to Book4.36
PEG Ratio—
Cash Flow
FCF Yield-4.09%
FCF / Share-$1.71
SBC-Adj FCF Yield-4.73%
SBC-Adj FCF / Share-$1.98
SBC Impact+15.44%
Margins & Growth
Gross Margin—
Operating Margin0.00%
Profit Margin0.00%
Quarterly Rev YoY0.00%
Quarterly EPS YoY+1.52%
Balance
Cash$45.21M
Debt$178.00K
Net Debt-$45.04M
Current Ratio30.79
Debt / Equity0.04
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
+73.21%
Sep 13, 2024 - May 8, 2026 · 414 daily points
Revenue
Net Income
↓ 209.1%Free Cash Flow
↓ 178.5%Diluted EPS
No data
Quick Stats
Open
$34.94
Day High
$41.28
Day Low
$34.56
Prev Close
$34.71
Market Cap
—
Volume
1,877,342
MBX Biosciences, Inc. Common Stock (MBX) analysis
Wrqti brings MBX Biosciences, Inc. Common Stock data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$40.97
Market cap
$1.95B
PE ratio
—
Price to book
4.36
Profit margin
0.00%
FCF yield
-4.09%
Stocks related to MBX Biosciences, Inc. Common Stock
Companies in the same sector you can compare with MBX Biosciences, Inc. Common Stock: